Equillium (EQ)
(Delayed Data from NSDQ)
$1.71 USD
-0.10 (-5.52%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.72 +0.01 (0.58%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Income Statements
Fiscal Year end for Equillium, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 36 | 16 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 36 | 16 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 51 | 78 | 38 | 30 | 27 |
Income After Depreciation & Amortization | -15 | -62 | -38 | -30 | -27 |
Non-Operating Income | 2 | 1 | 0 | 1 | 1 |
Interest Expense | 0 | 1 | 1 | 1 | 0 |
Pretax Income | -13 | -62 | -39 | -30 | -26 |
Income Taxes | 1 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -13 | -62 | -39 | -30 | -26 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -13 | -62 | -39 | -30 | -26 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -62 | -37 | -29 | -27 |
Depreciation & Amortization (Cash Flow) | -1 | 0 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -15 | -62 | -38 | -30 | -27 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 34.73 | 33.73 | 28.81 | 20.36 | 17.38 |
Diluted EPS Before Non-Recurring Items | -0.38 | -1.17 | -1.36 | -1.46 | -1.47 |
Diluted Net EPS (GAAP) | -0.38 | -1.85 | -1.36 | -1.46 | -1.47 |
Fiscal Year end for Equillium, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 9.21 | 8.87 | 9.12 | 8.88 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 9.21 | 8.87 | 9.12 | 8.88 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.41 | 12.49 | 12.72 | 12.99 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.20 | -3.62 | -3.60 | -4.11 |
Non-Operating Income | NA | 0.87 | 0.41 | 0.52 | 0.46 |
Interest Expense | NA | 0.00 | 0.00 | 0.26 | 0.23 |
Pretax Income | NA | -2.33 | -3.21 | -3.34 | -3.88 |
Income Taxes | NA | 0.02 | 0.50 | 0.01 | 0.06 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.34 | -3.71 | -3.34 | -3.94 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.34 | -3.71 | -3.34 | -3.94 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 35.15 | 34.88 | 34.45 | 34.41 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | -0.11 | -0.10 | -0.11 |
Diluted Net EPS (GAAP) | NA | -0.06 | -0.11 | -0.10 | -0.11 |